Tags

Type your tag names separated by a space and hit enter

mCPP: an undesired addition to the ecstasy market.
J Psychopharmacol. 2010 Sep; 24(9):1395-401.JP

Abstract

A new ecstasy-like substance, meta-chlorophenylpiperazine (mCPP), has been detected in street drugs in the Netherlands. Theoretically, mCPP possesses the potential to become a non-neurotoxic alternative for methylenedioxymethamphetamine (MDMA), the regular psychoactive substance of ecstasy. Since its introduction on the Dutch market of synthetic drugs, the percentage of mCPP-containing tablets has increased, including both tablets that contain only mCPP and tablets containing a combination of mCPP and MDMA. These tablets occur in many different colours, shapes and sizes and with various logos, making it impossible to distinguish mCPP-containing tablets from regular MDMA tablets. In addition, the reports of users concerning the effects of mCPP are predominantly negative. All these aspects together lead to the conclusion that mCPP is an undesired addition to the ecstasy market from the user's perspective.

Authors+Show Affiliations

Drug Information and Monitoring System (DIMS), Trimbos Institute for Mental Health and Addiction, Utrecht, The Netherlands. M.Bossong@umcutrecht.nlNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

19304863

Citation

Bossong, M G., et al. "MCPP: an Undesired Addition to the Ecstasy Market." Journal of Psychopharmacology (Oxford, England), vol. 24, no. 9, 2010, pp. 1395-401.
Bossong MG, Brunt TM, Van Dijk JP, et al. MCPP: an undesired addition to the ecstasy market. J Psychopharmacol (Oxford). 2010;24(9):1395-401.
Bossong, M. G., Brunt, T. M., Van Dijk, J. P., Rigter, S. M., Hoek, J., Goldschmidt, H. M., & Niesink, R. J. (2010). MCPP: an undesired addition to the ecstasy market. Journal of Psychopharmacology (Oxford, England), 24(9), 1395-401. https://doi.org/10.1177/0269881109102541
Bossong MG, et al. MCPP: an Undesired Addition to the Ecstasy Market. J Psychopharmacol (Oxford). 2010;24(9):1395-401. PubMed PMID: 19304863.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - mCPP: an undesired addition to the ecstasy market. AU - Bossong,M G, AU - Brunt,T M, AU - Van Dijk,J P, AU - Rigter,S M, AU - Hoek,J, AU - Goldschmidt,H M J, AU - Niesink,R J M, Y1 - 2009/03/20/ PY - 2009/3/24/entrez PY - 2009/3/24/pubmed PY - 2011/1/12/medline SP - 1395 EP - 401 JF - Journal of psychopharmacology (Oxford, England) JO - J. Psychopharmacol. (Oxford) VL - 24 IS - 9 N2 - A new ecstasy-like substance, meta-chlorophenylpiperazine (mCPP), has been detected in street drugs in the Netherlands. Theoretically, mCPP possesses the potential to become a non-neurotoxic alternative for methylenedioxymethamphetamine (MDMA), the regular psychoactive substance of ecstasy. Since its introduction on the Dutch market of synthetic drugs, the percentage of mCPP-containing tablets has increased, including both tablets that contain only mCPP and tablets containing a combination of mCPP and MDMA. These tablets occur in many different colours, shapes and sizes and with various logos, making it impossible to distinguish mCPP-containing tablets from regular MDMA tablets. In addition, the reports of users concerning the effects of mCPP are predominantly negative. All these aspects together lead to the conclusion that mCPP is an undesired addition to the ecstasy market from the user's perspective. SN - 1461-7285 UR - https://www.unboundmedicine.com/medline/citation/19304863/mCPP:_an_undesired_addition_to_the_ecstasy_market_ L2 - http://journals.sagepub.com/doi/full/10.1177/0269881109102541?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -